Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15432)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2019 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Harris PS, Hansen RM, Gray ME, Massoud OI, McGuire BM, Shoreibah MG. Hepatocellular carcinoma surveillance: An evidence-based approach. World J Gastroenterol 2019; 25(13): 1550-1559 [PMID: 30983815 DOI: 10.3748/wjg.v25.i13.1550] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i13/1550.htm |
| Number | Citing Articles |
| 1 |
George Cholankeril, Hashem B. El-Serag. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 2023; 43(01): 089 doi: 10.1055/a-1957-8540
|
| 2 |
Zhun Xiao, Fangming Yang, Zheng Liu, Xinju Chen, Suping Ma, Heng Li. An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241293019
|
| 3 |
Imen Akkari, Hanen Jaziri. Monitoring of hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(8): 991-993 doi: 10.3748/wjg.v30.i8.991
Abstract(307) |
Core Tip(324) |
Full Article(HTML)(1232)
|
Full Article with Cover (PDF)-700K(59)
|
Full Article (Word)-33K(10)
|
Audio-395K(8)
|
Peer-Review Report-199K(42)
|
Answering Reviewers-42K(46)
|
Full Article (PDF)-328K(86)
|
Full Article (XML)-20K(44)
|
Times Cited (0)
|
Total Visits (2936)
|
Open
|
| 4 |
Jimmy Che-To Lai, Vicki Wing-Ki Hui, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip. Hepatocellular carcinoma surveillance after HBsAg seroclearance. Exploration of Digestive Diseases 2024; : 175 doi: 10.37349/edd.2024.00046
|
| 5 |
Roongruedee Chaiteerakij, Darlene Ariyaskul, Kittipat Kulkraisri, Terapap Apiparakoon, Sasima Sukcharoen, Oracha Chaichuen, Phaiboon Pensuwan, Thodsawit Tiyarattanachai, Rungsun Rerknimitr, Sanparith Marukatat. Artificial intelligence for ultrasonographic detection and diagnosis of hepatocellular carcinoma and cholangiocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71657-z
|
| 6 |
Xinyi Wang, Jianyong Lei, Zhihui Li, Lunan Yan. Potential Effects of Coronaviruses on the Liver: An Update. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.651658
|
| 7 |
Shuang Jiang, Guangcong Zhang, Yanan Ma, Dongyu Wu, Da Xie, Songke Zhou, Xuemei Jiang. Ferroptosis in hepatocellular carcinoma, from mechanism to effect. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1350011
|
| 8 |
Zejian (Eric) Wu, Da Xu, Paul Jen-Hwa Hu, Liang Li, Ting-Shuo Huang. A meta-path, attention-based deep learning method to support hepatitis carcinoma predictions for improved cirrhosis patient management. Decision Support Systems 2024; 181: 114226 doi: 10.1016/j.dss.2024.114226
|
| 9 |
Omar Kamal, Natally Horvat, Sandeep Arora, Humaira Chaudhry, Mohab Elmohr, Lokesh Khanna, Pankaj Sharma Nepal, Manida Wungjramirun, Sadhna B. Nandwana, Anuradha S. Shenoy-Bhangle, James Lee, Ania Kielar, Robert Marks, Khaled Elsayes, Alice Fung. Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinoma. Abdominal Radiology 2023; 48(12): 3677 doi: 10.1007/s00261-023-04033-6
|
| 10 |
Shaimaa Almohaid, Saeed Akhtar. Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12409-0
|
| 11 |
Ya Chen, Yuan Jiang, Xinyu Huang, Lin Chen, Hao Yang, Jian Zhao, Beibei Liang, Xu Wu. Cordycepin Inhibits the Growth of Hepatocellular Carcinoma by Regulating the Pathway of Aerobic Glycolysis. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6454482
|
| 12 |
Min Yao, Ping Zhou, Yan-Yan Qin, Li Wang, Deng-Fu Yao. Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis. World Journal of Gastroenterology 2023; 29(12): 1765-1778 doi: 10.3748/wjg.v29.i12.1765
|
| 13 |
Xu-Sheng Zhang, Hong-Cai Zhou, Peng Wei, Long Chen, Wei-Hu Ma, Lin Ding, Shi-Cai Liang, Ben-Dong Chen. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses. World Journal of Gastrointestinal Oncology 2023; 15(12): 2138-2149 doi: 10.4251/wjgo.v15.i12.2138
Abstract(348) |
Core Tip(366) |
Full Article(HTML)(1392)
|
Full Article with Cover (PDF)-10469K(58)
|
Full Article (Word)-3354K(24)
|
Audio-263K(6)
|
Peer-Review Report-209K(44)
|
Answering Reviewers-113K(41)
|
Full Article (PDF)-10227K(82)
|
Full Article (XML)-89K(41)
|
Times Cited (2)
|
Total Visits (4135)
|
Open
|
| 14 |
Nan Zhang, Hui Xu, A‐Hong Ren, Qian Zhang, Da‐Wei Yang, Te Ba, Zhen‐Chang Wang, Zheng‐Han Yang. Does Training in LI‐RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter‐reader Agreement in MRI Interpretation?. Journal of Magnetic Resonance Imaging 2021; 54(6): 1922 doi: 10.1002/jmri.27688
|
| 15 |
Xiao-Fei Zhao, Ning Li, Dong-Dong Lin, Li-Bo Sun. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5353695
|
| 16 |
Wei Zhang, Zhong Chen, Chengjun Xue, Yao Zhang, Lipei Wu, Jichao Zhu, Shihai Xuan, Jiale Tian, Zhi Pang. The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.740029
|
| 17 |
Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee. Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection. European Journal of Gastroenterology & Hepatology 2023; 35(4): 431 doi: 10.1097/MEG.0000000000002504
|
| 18 |
Afrouz Ataei, Jun Deng, Wazir Muhammad. Liver cancer risk quantification through an artificial neural network based on personal health data. Acta Oncologica 2023; 62(5): 495 doi: 10.1080/0284186X.2023.2213445
|
| 19 |
Chuanwen Yu, Chuang Sun, Shangxiang Chen. Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6581127
|
| 20 |
Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima. Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Diagnostics 2020; 10(8): 579 doi: 10.3390/diagnostics10080579
|
| 21 |
Eva A. van Aalen, Simone F. A. Wouters, Dennis Verzijl, Maarten Merkx. Bioluminescent RAPPID Sensors for the Single-Step Detection of Soluble Axl and Multiplex Analysis of Cell Surface Cancer Biomarkers. Analytical Chemistry 2022; 94(17): 6548 doi: 10.1021/acs.analchem.2c00297
|
| 22 |
Claudia Maccali, Isabel V. A. Pereira, José Tadeu Stefano, Claudia P. Oliveira. Risk of Liver Cancer in MASLD: Role of Genetic Risk Scores. Current Hepatology Reports 2023; 22(4): 228 doi: 10.1007/s11901-023-00623-6
|
| 23 |
Peng Deng, Mi Li, Yuni Wu, Enas Abdulhay. The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/5914541
|
| 24 |
Xiao Wang, Keyan Wang, Cuipeng Qiu, Bofei Wang, Xiaojun Zhang, Yangcheng Ma, Liping Dai, Jian-Ying Zhang. Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients. Biomedicines 2022; 10(1): 97 doi: 10.3390/biomedicines10010097
|
| 25 |
Prasanna Ramachandran, Gege Xu, Hector H. Huang, Rachel Rice, Bo Zhou, Klaus Lindpaintner, Daniel Serie. Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Journal of Proteome Research 2022; 21(4): 1083 doi: 10.1021/acs.jproteome.1c00965
|
| 26 |
L. S. Antipina, G. Ts. Dambaev, D. V. Vasilchenko, M. M. Solovev, A. P. Pisarev. Nodular hepatocellular carcinoma. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2023; 28(4): 88 doi: 10.16931//1995-5464.2023-4-88-92
|
| 27 |
Narayanan Sadagopan, Aiwu Ruth He. Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(2): 1259 doi: 10.3390/ijms25021259
|
| 28 |
Alexsis Garcia, Stephen O. Mathew. Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma. Cancers 2024; 16(13): 2446 doi: 10.3390/cancers16132446
|
| 29 |
Hongmei Jin, Hui Wang, Guanghao Li, Qingshun Hou, Wei Wu, Fuhui Liu. Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma. Journal of International Medical Research 2020; 48(10) doi: 10.1177/0300060520961260
|
| 30 |
Jelena Djokic Kovac, Aleksandar Ivanovic, Tamara Milovanovic, Marjan Micev, Francesco Alessandrino, Richard M. Gore. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiology and Oncology 2021; 55(2): 130 doi: 10.2478/raon-2021-0004
|
| 31 |
Hua Liu, Jing Cheng, Heng Xu, Zhenzhen Wan. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis. Open Life Sciences 2021; 16(1): 766 doi: 10.1515/biol-2021-0072
|
| 32 |
Ahila Manivannan, Samia Mazumder, Nabil Al-Kourainy. The Role of Hepatocellular Carcinoma Surveillance in Autoimmune Hepatitis. Cureus 2020; doi: 10.7759/cureus.11269
|
| 33 |
Hailey H. Choi, Stephanie Kim, Dorothy J. Shum, Chiung-Yu Huang, Amy Shui, Rena K. Fox, Mandana Khalili. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance. Radiology: Imaging Cancer 2024; 6(1) doi: 10.1148/rycan.230118
|
| 34 |
Eliza W. Beal, Mackenzie Owen, Molly McNamara, Ann Scheck McAlearney, Allan Tsung. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping Review. Journal of Gastrointestinal Cancer 2023; 54(2): 332 doi: 10.1007/s12029-022-00851-x
|
| 35 |
Jianlong Jia, Latai Ga, Yang Liu, Zhiyi Yang, Yue Wang, Xuanze Guo, Ruichen Ma, Ruonan Liu, Tianyou Li, Zeyao Tang, Jun Wang. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.923031
|
| 36 |
Shu-Ling Chen, Chia-Ying Ho, Wei-Chun Lin, Chao-Wei Lee, Yu-Chun Chen, Jiun-Liang Chen, Hsing-Yu Chen. The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs. International Journal of Environmental Research and Public Health 2022; 19(19): 12480 doi: 10.3390/ijerph191912480
|
| 37 |
Heinz-Peter Schlemmer. The Cancer Epidemic. Die Radiologie 2023; 63(1): 49 doi: 10.1007/s00117-022-01092-6
|
| 38 |
Liming Zheng, Zeyu Huang, Xiaoping Li, Meifang He, Xiaoqin Liu, Guojun Zheng, Xike Zhou, Longgen Liu. Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02489-2
|
| 39 |
Shen Li, Antonio Saviano, Derek J. Erstad, Yujin Hoshida, Bryan C. Fuchs, Thomas Baumert, Kenneth K. Tanabe. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. Journal of Clinical Medicine 2020; 9(12): 3817 doi: 10.3390/jcm9123817
|
| 40 |
Seung Baek Hong, Dong Hwan Kim, Sang Hyun Choi, So Yeon Kim, Ji Sung Lee, Nam Kyung Lee, Joon-Il Choi. Inadequate Ultrasound Examination in Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(16): 3535 doi: 10.3390/jcm10163535
|
| 41 |
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
|
| 42 |
Wenjie Xu, Shuyi Liu, Genshan Zhang, Jin Liu, Gang Cao. Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells. Journal of Chemotherapy 2023; 35(5): 455 doi: 10.1080/1120009X.2022.2143614
|
| 43 |
Gehad Ahmad Saleh, Ahmed Abdel Khalek Abdel Razek, Lamiaa Galal El-Serougy, Walaa Shabana, Rihame Abd El-Wahab. The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System version 2018. Polish Journal of Radiology 2022; 87: 43 doi: 10.5114/pjr.2022.113193
|
| 44 |
Atsushi Kudo, Masahiro Shinoda, Shunichi Ariizumi, Takafumi Kumamoto, Masafumi Katayama, Takehito Otsubo, Itaru Endo, Yuko Kitagawa, Minoru Tanabe, Masakazu Yamamoto. Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402. Journal of Cancer Research and Clinical Oncology 2020; 146(11): 2949 doi: 10.1007/s00432-020-03270-2
|
| 45 |
C.A. Marschner, L. Zhang, V. Schwarze, W. Völckers, M.F. Froelich, N. von Münchhausen, M.L. Schnitzer, T. Geyer, M.P. Fabritius, J. Rübenthaler, D.-A. Clevert. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1. Clinical Hemorheology and Microcirculation 2021; 76(4): 453 doi: 10.3233/CH-209221
|
| 46 |
Wenhao Li, Polychronis Kemos, Justin D. Salciccioli, Dominic C. Marshall, Joseph Shalhoub, William Alazawi. Socioeconomic Factors Associated With Liver-Related Mortality From 1985 to 2015 in 36 Developed Countries. Clinical Gastroenterology and Hepatology 2021; 19(8): 1698 doi: 10.1016/j.cgh.2020.08.047
|
| 47 |
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosis. Academic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
|
| 48 |
Dongyang Wu, Qingshan Cai, Dong Liu, Ganggang Zuo, Shudong Li, Liyou Liu, Jianxing Zheng. Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma: A review. Medicine 2023; 102(10): e33228 doi: 10.1097/MD.0000000000033228
|
| 49 |
Doha M. AbdElaleem, Safia M. Mohammed, Olfat M. Hendy, Neamat A. Abdelmageed. Serum midkine level as a diagnostic biomarker of hepatocellular carcinoma in Egyptian patients with chronic hepatitis C. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2022; 6(1): 75 doi: 10.4103/sjamf.sjamf_216_21
|
| 50 |
Hengdong Qu, Junli Liu, Di Zhang, Ruoyan Xie, Lijuan Wang, Jian Hong. Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic Opportunities. Cells 2023; 12(15): 1930 doi: 10.3390/cells12151930
|
| 51 |
Daryl Ramai, Jameel Singh, Saurabh Chandan, Nicola Tartaglia, Antonio Ambrosi, Shahab R. Khan, Rodolfo Sacco, Antonio Facciorusso. Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis. Journal of Clinical Gastroenterology 2023; 57(2): 198 doi: 10.1097/MCG.0000000000001668
|
| 52 |
Shiyue Zhou, Zixuan Zhao, Hao Zhong, Zehao Ren, Yuye Li, Hong Wang, Yuling Qiu. The role of myeloid-derived suppressor cells in liver cancer. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00681-8
|
| 53 |
V. V. Breder, R. B. Alikhanov, S. S. Bagnenko, E. N. Bessonova, V. A. Isakov, N. E. Kudashkin, B. M. Medvedeva, A. V. Mishchenko, M. S. Novruzbekov, V. S. Rudakov. Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 32(5): 16 doi: 10.22416/1382-4376-2022-32-5-16-23
|
| 54 |
Rong Fan, George Papatheodoridis, Jian Sun, Hamish Innes, Hidenori Toyoda, Qing Xie, Shuyuan Mo, Vana Sypsa, Indra Neil Guha, Takashi Kumada, Junqi Niu, George Dalekos, Satoshi Yasuda, Eleanor Barnes, Jianqi Lian, Vithika Suri, Ramazan Idilman, Stephen T. Barclay, Xiaoguang Dou, Thomas Berg, Peter C. Hayes, John F. Flaherty, Yuanping Zhou, Zhengang Zhang, Maria Buti, Sharon J. Hutchinson, Yabing Guo, Jose Luis Calleja, Lanjia Lin, Longfeng Zhao, Yongpeng Chen, Harry L.A. Janssen, Chaonan Zhu, Lei Shi, Xiaoping Tang, Anuj Gaggar, Lai Wei, Jidong Jia, William L. Irving, Philip J. Johnson, Pietro Lampertico, Jinlin Hou. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. Journal of Hepatology 2020; 73(6): 1368 doi: 10.1016/j.jhep.2020.07.025
|
| 55 |
Puo-Hsien Le, Chia-Jung Kuo, Yi-Chung Hsieh, Tsung-Hsing Chen, Chih-Lang Lin, Chau-Ting Yeh, Kung-Hao Liang. Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variation. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6409-3
|
| 56 |
Lei Zhao, Houbin Zhang, Peiyou Ren, Xiangjun Sun. LncRNA SLC9A3-AS1 knockdown increases the sensitivity of liver cancer cell to triptolide by regulating miR-449b-5p-mediated glycolysis. Biotechnology and Genetic Engineering Reviews 2024; 40(2): 1389 doi: 10.1080/02648725.2023.2193775
|
| 57 |
Raphaël Girardet, Margaux Dubois, Gibran Manasseh, Mario Jreige, Céline Du Pasquier, Emma Canniff, Marianna Gulizia, Melissa Bonvin, Yasser Aleman, Bachir Taouli, Montserrat Fraga, Clarisse Dromain, Naik Vietti Violi. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening. European Radiology 2023; 33(10): 6929 doi: 10.1007/s00330-023-09906-4
|
| 58 |
Paul Smereka, Ankur M. Doshi, Lisa P. Lavelle, Krishna Shanbhogue. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification. American Journal of Roentgenology 2020; 215(2): 382 doi: 10.2214/AJR.19.22033
|
| 59 |
Guangxin Yan, Zhihui Chang, Chuanzhuo Wang, Zheng Gong, He Xin, Zhaoyu Liu. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628–5p/MEIS2 axis to activate the Notch pathway. Digestive and Liver Disease 2022; 54(1): 125 doi: 10.1016/j.dld.2021.04.036
|
| 60 |
Yukihiro Shirota, Yoshimichi Ueda, Katsuaki Sato, Yasuhito Takeda, Yuji Hodo, Tokio Wakabayashi. Solitary extrahepatic hepatocellular carcinoma in vertebrae without a primary lesion in the liver might originate from bone marrow: a case report and new hypothesis based on a review of the literature and the latest findings. Clinical Journal of Gastroenterology 2022; 15(6): 1115 doi: 10.1007/s12328-022-01701-w
|
| 61 |
Joshua P Kronenfeld, Neha Goel. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1209 doi: 10.2147/JHC.S284430
|
| 62 |
Jiaoxia He, Zhongling Zheng, Tingting Liu, Yupei Ao, Yixuan Yang, Huaidong Hu. Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18894-2
|
| 63 |
Luwen Xing, Yiwen Zhang, Saiyu Li, Minghui Tong, Kaishun Bi, Qian Zhang, Qing Li. A Dual Coverage Monitoring of the Bile Acids Profile in the Liver–Gut Axis throughout the Whole Inflammation-Cancer Transformation Progressive: Reveal Hepatocellular Carcinoma Pathogenesis. International Journal of Molecular Sciences 2023; 24(5): 4258 doi: 10.3390/ijms24054258
|
| 64 |
Ashraf Khalil, Ashraf Elfert, Samar Ghanem, Marwa Helal, Shymaa Abdelsattar, Gamalate Elgedawy, Manar Obada, Mohamed Abdel-Samiee, Hala El-Said. The role of metabolomics in hepatocellular carcinoma. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00085-9
|
| 65 |
Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang. A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population. Cancer Medicine 2024; 13(9) doi: 10.1002/cam4.7230
|
| 66 |
Raoul C Reulen, Kwok F Wong, Chloe J Bright, David L Winter, Daniela Alessi, Rodrigue M Allodji, Francesca Bagnasco, Edit Bárdi, Andrea Bautz, Julianne Byrne, Elizabeth AM Feijen, Miranda M Fidler-Benaoudia, Ibrahim Diallo, Stanislaw Garwicz, Desiree Grabow, Thorgerdur Gudmundsdottir, Joyeeta Guha, Nadia Haddy, Stine Høgsholt, Moncilo Jankovic, Peter Kaatsch, Melanie Kaiser, Rahel Kuonen, Helena Linge, Hilde Øfstaas, Cecile M Ronckers, Eva-Maria Hau, Roderick Skinner, Flora E van Leeuwen, Jop C Teepen, Cristina Veres, Wael Zrafi, Ghazi Debiche, Damien Llanas, Monica Terenziani, Giao Vu-Bezin, Finn Wesenberg, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Riccardo Haupt, Päivi M Lähteenmäki, Lorna Zadravec Zaletel, Claudia E Kuehni, Jeanette F Winther, Florent de Vathaire, Leontien C Kremer, Lars Hjorth, Michael M Hawkins. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. Gut 2021; 70(8): 1520 doi: 10.1136/gutjnl-2020-322237
|
| 67 |
Yue Li, Shou-Li Yuan, Jing-Ya Yin, Kun Yang, Xin-Gang Zhou, Wen Xie, Qi Wang. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis. World Journal of Gastrointestinal Oncology 2022; 14(7): 1265-1280 doi: 10.4251/wjgo.v14.i7.1265
|
| 68 |
Yue Cai, Deng Wu, Lei Zhan. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis. Clinics and Research in Hepatology and Gastroenterology 2022; 46(3): 101796 doi: 10.1016/j.clinre.2021.101796
|
| 69 |
Zhuo Wang, Aishi Wang, Qiao Liu, Shuanglian Wang, Xuantao Su, Valery V. Tuchin, Qingming Luo, Lihong V. Wang. Label-free analysis of single microparticles and nanoscale exosomes with two-dimensional light scattering technology. Sixteenth International Conference on Photonics and Imaging in Biology and Medicine (PIBM 2023) 2023; : 15 doi: 10.1117/12.2682909
|
| 70 |
聪聪 谭. Advances in the Diagnosis and Treatment of Exosomal miRNA in Liver Cancer. Advances in Clinical Medicine 2024; 14(05): 2093 doi: 10.12677/acm.2024.1451655
|
| 71 |
Janyssa Charbonneau, Thomas Couture, Alexis Turgeon, Sarah O'Connor, Jean-François Ouellet, Jean-François Berthin Ouellet, Alexandre Brind’Amour. Oncological outcomes of tumor ablation compared to surgical resection in early-stage hepatocellular carcinomas: a systematic review with meta-analysis. HPB 2024; 26(12): 1448 doi: 10.1016/j.hpb.2024.08.008
|
| 72 |
Pengfei Ren, Keyan Wang, Jie Ma, Xiaoqin Cao, Jiuzhou Zhao, Chengzhi Zhao, Yongjun Guo, Hua Ye. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer. Journal of Hepatocellular Carcinoma 2022; : 221 doi: 10.2147/JHC.S352057
|
| 73 |
Fei Feng, Yue Zhao. Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment. Medical Principles and Practice 2024; 33(5): 414 doi: 10.1159/000539349
|
| 74 |
Nathan Bryan, Arash Zandieh, Bhaskar Kallakury, Stuart Kaufman, Nada Yazigi, Rafaele Girlanda, Jason Hawksworth, Thomas Fishbein, Cal Matsumoto, Alexander Kroemer, Khalid Khan. De novo hepatocellular carcinoma 18 years after liver and small bowel transplantation in a one‐year‐old pediatric patient. Pediatric Transplantation 2021; 25(2) doi: 10.1111/petr.13820
|
| 75 |
Mohammad Golriz, Ali Ramouz, Sadeq Ali-Hasan-Al-Saegh, Saeed Shafiei, Ehsan Aminizadeh, Ahmed Hammad, Markus Mieth, Christian Rupp, Christoph Springfeld, Katrin Hoffmann, Markus Büchler, Arianeb Mehrabi. Prognostic Value of Red Blood Cell Distribution Width (RDW) in the Recurrence of Hepatocellular Carcinoma Following Curative Resection. Journal of Hepatocellular Carcinoma 2022; : 1137 doi: 10.2147/JHC.S380243
|
| 76 |
Hideki Fujii, Hiroyuki Kimura, Chitomi Hasebe, Takehiro Akahane, Takashi Satou, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Hiroyuki Marusawa, Haruhiko Kobashi, Keiji Tsuji, Chikara Ogawa, Yasushi Uchida, Kouji Joko, Akeri Mitsuda, Masayuki Kurosaki, Namiki Izumi. Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection. JGH Open 2022; 6(5): 344 doi: 10.1002/jgh3.12749
|
| 77 |
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu, Yunfu Cui. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204715
|
| 78 |
Huan Deng, Xiude Fan, Xiaoyun Wang, Lu Zeng, Kun Zhang, Xiaoge Zhang, Na Li, Qunying Han, Yi Lv, Zhengwen Liu. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77332-3
|
| 79 |
Osvaldo Ulises Garay, Louisa Elena Ambühl, Thomas G. Bird, Eleanor Barnes, William L. Irving, Ryan Walkley, Ian A. Rowe. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom. Value in Health 2024; doi: 10.1016/j.jval.2024.07.015
|
| 80 |
Christina C. Köpping-Segerling, Michael Pohl, Ali Canbay, Jan Best. Hepatozelluläres Karzinom – Screening und Surveillance. Die Gastroenterologie 2022; 17(6): 387 doi: 10.1007/s11377-022-00651-6
|
| 81 |
Min Yang, Huiqin Zhang, Jieqiu Zhang, Xiaopeng Yao. Risk factors and prevention of liver cancer: A bibliometric and visual analysis. Medicine 2023; 102(47): e35740 doi: 10.1097/MD.0000000000035740
|
| 82 |
Raquel Ríos León, Eugenia Sánchez Rodríguez , Antonio Martínez Ortega, Enrique Rodríguez de Santiago, Natalia Marcos Carrasco, Javier Graus Morales, Miguel Ángel Rodríguez Gandía, Jose Luis Lledó Navarro, Francisco Gea Rodríguez, Javier María Nuño Vázquez Garza, Agustín Albillos Martínez, Miguel García González . Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study. Revista Española de Enfermedades Digestivas 2021; doi: 10.17235/reed.2021.7744/2020
|
| 83 |
Yasuyuki Tamai, Motoh Iwasa, Akiko Eguchi, Ryuta Shigefuku, Ryosuke Sugimoto, Hideaki Tanaka, Yoshinao Kobayashi, Shugo Mizuno, Hayato Nakagawa. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment. European Journal of Gastroenterology & Hepatology 2022; 34(12): 1269 doi: 10.1097/MEG.0000000000002459
|
| 84 |
Xiangyu Kong, Zhen He, Zhaohua Ji, Ting Fu, Xiaojie Yuan, Haowei Zhou, Zhongjun Shao, Weilu Zhang. A Circulating MicroRNA-375 for the Detection of Liver Cancer: A Meta-Analysis. Genetic Testing and Molecular Biomarkers 2022; 26(12): 564 doi: 10.1089/gtmb.2022.0128
|
| 85 |
Dattatrya Shetti, Venkata Ramana Mallela, Wenjing Ye, Mahyar Sharif, Filip Ambrozkiewicz, Andriy Trailin, Václav Liška, Kari Hemminki. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2024; 200: 104391 doi: 10.1016/j.critrevonc.2024.104391
|
| 86 |
Qisthina Syifa Setiawan, Zuherman Rustam, Sri Hartini, Afifah Rofi Laeli, Ilsya Wirasati. Comparison of Naive Bayes and Decision Tree for Classifying Hepatocellular Carcinoma (HCC). 2020 International Conference on Innovation and Intelligence for Informatics, Computing and Technologies (3ICT) 2020; : 1 doi: 10.1109/3ICT51146.2020.9312022
|
| 87 |
Qian Ding, Dongdong Lin, Yajing Zhou, Feng Li, Jianming Lai, Jianping Duan, Jing Chen, Caihua Jiang. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL‑6/JAK/STAT3 pathway activation in hepatocellular carcinoma. Oncology Letters 2021; 22(6) doi: 10.3892/ol.2021.13118
|
| 88 |
Xianyu Chen, Yongsheng Tang, Donghao Wu, Ruixi Li, Zhiqun Lin, Xuhui Zhou, Hezhen Wang, Hang Zhai, Junming Xu, Xianjie Shi, Guangquan Zhang. From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1278467
|
| 89 |
Thitiporn Pathomjaruwat, Yaowarat Matchim, Jane M. Armer. Symptoms and symptom clusters in patients with hepatocellular carcinoma and commonly used instruments: An integrated review. International Journal of Nursing Sciences 2024; 11(1): 66 doi: 10.1016/j.ijnss.2023.09.009
|
| 90 |
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review. Diagnostics 2023; 13(4): 625 doi: 10.3390/diagnostics13040625
|
| 91 |
Zhuolin Li, Yao Lin, Bizhen Cheng, Qiaoxin Zhang, Yingmu Cai. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.571231
|
| 92 |
Averill Guo, Sydney Pomenti, Julia Wattacheril. Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma. Clinical Liver Disease 2021; 17(5): 353 doi: 10.1002/cld.1057
|
| 93 |
Kelly Casler, Amanda Chaney. Cirrhosis. The Nurse Practitioner 2020; 45(8): 16 doi: 10.1097/01.NPR.0000681772.39310.d0
|
| 94 |
Yuemin Nan, Osvaldo Ulises Garay, Xianzhong Lu, Yue Zhang, Li Xie, Zhongyi Niu, Wen Chen. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis. Journal of Comparative Effectiveness Research 2024; 13(4) doi: 10.57264/cer-2023-0146
|
| 95 |
Chuanzong Zhao, Ben Wang, Enyu Liu, Zongli Zhang. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma. Cell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00622-w
|
| 96 |
Thais Maloberti, Antonio De Leo, Viviana Sanza, Elisa Gruppioni, Annalisa Altimari, Mattia Riefolo, Michela Visani, Deborah Malvi, Antonia D’Errico, Giovanni Tallini, Francesco Vasuri, Dario de Biase. Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center. World Journal of Gastroenterology 2022; 28(25): 2854-2866 doi: 10.3748/wjg.v28.i25.2854
|
| 97 |
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
|
| 98 |
Frances J. Bennett, Jessica M. Keilson, Michael K. Turgeon, Kailey M. Oppat, Emilie A. K. Warren, Shimul A. Shah, Vatche G. Agopian, Joseph F. Magliocca, Andrew Cameron, Susan L. Orloff, Chandrashekhar A. Kubal, Robert M. Cannon, Mohamed E. Akoad, Juliet Emamaullee, Federico Aucejo, Parsia A. Vagefi, Mindie H. Nguyen, Kiran Dhanireddy, Marwan M. Kazimi, Christopher J. Sonnenday, David P. Foley, Marwan Abdouljoud, Debra L. Sudan, Abhinav Humar, M. B. Majella Doyle, William C. Chapman, Shishir K. Maithel. Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma. Annals of Surgical Oncology 2024; doi: 10.1245/s10434-024-16317-2
|
| 99 |
Philip J. Johnson, Ehsan Bhatti, Hidenori Toyoda, Shan He. Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models. JCO Clinical Cancer Informatics 2024; (8) doi: 10.1200/CCI.23.00199
|
| 100 |
Zhiwen Lai, Tianning Wei, Qingming Li, Xianglong Wang, Yang Zhang, Shengliang Zhang. Exosomal circFBLIM1 Promotes Hepatocellular Carcinoma Progression and Glycolysis by Regulating the miR-338/LRP6 Axis. Cancer Biotherapy and Radiopharmaceuticals 2023; 38(10): 674 doi: 10.1089/cbr.2020.3564
|
| 101 |
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver and COVID-19: From care of patients with liver diseases to liver injury. World Journal of Hepatology 2021; 13(10): 1367-1377 doi: 10.4254/wjh.v13.i10.1367
|
| 102 |
Ryan Alberts, AnnMarie Zimmermann, Anthony Martinez. Improving hepatitis C screening and access to treatment. JAAPA 2022; 35(10): 17 doi: 10.1097/01.JAA.0000873784.48761.b2
|
| 103 |
Andrew McDonald, Chen Dai, Qingrui Meng, Lindsey Hageman, Joshua Richman, Jessica Wu, Liton Francisco, Elizabeth Ross, Nora Balas, Alysia Bosworth, Hok Sreng Te, F. Lennie Wong, Wendy Landier, Donna Salzman, Ravi Bhatia, Daniel J. Weisdorf, Stephen J. Forman, Saro H. Armenian, Smita Bhatia. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant. JAMA Oncology 2023; 9(3): 376 doi: 10.1001/jamaoncol.2022.6569
|
| 104 |
Shiqi Hu, Yaqin Liu, Qidong Yang, Lin Chen, Huizi Chai, Mingzhe Xiao, Chuang Qi, Wei Qiu. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma. Investigational New Drugs 2023; 41(3): 532 doi: 10.1007/s10637-023-01363-6
|
| 105 |
A. S. Shkaraburov, D. N. Rudenko, E. F. Vaiman, O. M. Soboleva, Yu. V. Zakharova. Asymptomatic Hepatocellular Carcinoma (Clinical Case). Creative surgery and oncology 2022; 12(3): 256 doi: 10.24060/2076-3093-2022-12-3-256-260
|
| 106 |
Gehad A. Saleh, Ali H. Elmokadem, Ahmed Abdel Razek, Ahmed El-Morsy, Omar Hamdy, Elshimaa S. Eleraky, Marwa Saleh. Utility of diffusion tensor imaging in differentiating benign from malignant hepatic focal lesions. European Radiology 2022; 33(2): 1400 doi: 10.1007/s00330-022-09091-w
|
| 107 |
Emily Truong, Cheng Han, Mark Muthiah, Mazen Noureddin. Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2023; 22(1): 1 doi: 10.1007/s11901-023-00595-7
|
| 108 |
Hao Cui, Ye Qi, Chunyue Guo, Naijun Tang. The effect of PM2.5 exposure on the mortality of patients with hepatocellular carcinoma in Tianjin, China. Environmental Science and Pollution Research 2023; 30(32): 78632 doi: 10.1007/s11356-023-28039-1
|
| 109 |
Lauren J. McEneaney, Mathew Vithayathil, Shahid Khan. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 271 doi: 10.1002/9781119756422.ch16
|
| 110 |
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
|
| 111 |
Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Marty T. Sellers, Nima Kokabi, Alessandro Granito. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9926704
|
| 112 |
Qinfan Yao, Xiuyuan Zhang, Dajin Chen. Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.848296
|
| 113 |
William A. Preston, Nina R. Spitofsky, Adam S. Bodzin. A Contemporary Review of Robotic Resection for Hepatocellular Carcinoma. Cancers 2024; 16(22): 3806 doi: 10.3390/cancers16223806
|
| 114 |
Yungang Zhu, Baoguo Li, Guoping Xu, Changrui Han, Gang Xing. lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expression. Molecular Medicine Reports 2021; 25(1) doi: 10.3892/mmr.2021.12554
|
| 115 |
Hanchuan Tao, Cheng Wang, Chongmei Lu, Ning Ma, Yifan Zhu, Shihai Xuan, Xiaojun Zhou, Yaying Sun. Comprehensive Analysis on the Specific Role and Function of Mitochondrial Inner Membrane Protein MPV17 in Liver Hepatocellular Carcinoma. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/7236823
|
| 116 |
Aisling Barry, Smith Apisarnthanarax, Grainne M O'Kane, Gonzalo Sapisochin, Robert Beecroft, Riad Salem, Sang Min Yoon, Young-Suk Lim, John Bridgewater, Brian Davidson, Marta Scorsetti, Luigi Solbiati, Adam Diehl, Pablo Munoz Schuffenegger, Jonathan G Sham, David Cavallucci, Zita Galvin, Laura A Dawson, Maria A Hawkins. Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. The Lancet Gastroenterology & Hepatology 2020; 5(8): 765 doi: 10.1016/S2468-1253(20)30182-5
|
| 117 |
Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li. Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China. International Journal of Clinical Pharmacy 2024; 46(2): 429 doi: 10.1007/s11096-023-01675-w
|
| 118 |
Mingming Fei, Xianying Li, Shuhang Liang, Shuo Zhou, Huihui Wu, Linmao Sun, Yao Liu, Qingsong Hu, Lianxin Liu, Jiabei Wang. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity. Cancer Letters 2024; 584: 216620 doi: 10.1016/j.canlet.2024.216620
|
| 119 |
Krisna P. Chai, Varun Saxena, Suk Seo, Brandon H. Horton, Andrew L. Avins, Mai Sedki, Joanna B. Ready. A Chronic Hepatitis B Identification and Surveillance Program Improves Care in an Integrated Health Plan. American Journal of Gastroenterology 2024; doi: 10.14309/ajg.0000000000003116
|
| 120 |
|
| 121 |
Bo Li, Youyun Zhao, Wangxi Cai, Anping Ming, Hanmin Li. Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma. Clinical Proteomics 2021; 18(1) doi: 10.1186/s12014-021-09326-w
|
| 122 |
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma. Research Journal of Pharmacy and Technology 2023; : 377 doi: 10.52711/0974-360X.2023.00065
|
| 123 |
Yongqing Tang, Shun‐ichi Sasaki, Joshua Hawley, Aurélie Peillon, Anders Sjöström, Adolfo Fuentes‐Alburo, Francois Tranquart. Diagnostic Test Accuracy of Contrast‐Enhanced Ultrasound With Sonazoid for Assessment of Focal Liver Lesions: A Systematic Review and Meta‐Analysis. Journal of Clinical Ultrasound 2024; doi: 10.1002/jcu.23879
|
| 124 |
Olayinka Fisayo Onifade, Oluseyi Adeboye Akinloye, Oluwatosin A. Dosumu, Abdul Lateef Aderemi Shotuyo. In silico and in vivo anti-angiogenic validation on ethanolic extract of Curcuma longa and curcumin compound in hepatocellular carcinoma through mitogen activated protein kinase expression in male and female wistar rats. Food and Chemical Toxicology 2023; 182: 114096 doi: 10.1016/j.fct.2023.114096
|
| 125 |
Joshua P. Kronenfeld, Emily L. Ryon, David Goldberg, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Alan S. Livingstone, Nipun B. Merchant, Neha Goel. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study. Annals of Surgical Oncology 2021; 28(4): 1929 doi: 10.1245/s10434-020-09156-4
|
| 126 |
Ahmed Haitham Abduljabbar. Diagnostic accuracy of ultrasound and alpha-fetoprotein measurement for hepatocellular carcinoma surveillance: a retrospective comparative study. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-00982-6
|
| 127 |
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
|
| 128 |
Kelly Casler, Amanda Chaney. Cirrhosis. Nursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
|
| 129 |
Yi-Ming Qi, En-Hua Xiao. Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosis. World Journal of Gastroenterology 2023; 29(28): 4384-4396 doi: 10.3748/wjg.v29.i28.4384
Abstract(615) |
Core Tip(602) |
Full Article(HTML)(2896)
|
Full Article with Cover (PDF)-1882K(107)
|
Full Article (Word)-401K(44)
|
Audio-664K(2)
|
Peer-Review Report-198K(51)
|
Answering Reviewers-132K(61)
|
Full Article (PDF)-1523K(190)
|
Full Article (XML)-246K(45)
|
Times Cited (5)
|
Total Visits (6108)
|
Open
|
| 130 |
Sobia Zaidi, Richard Amdur, Xiyan Xiang, Herbert Yu, Linda L. Wong, Shuyun Rao, Aiwu R. He, Karan Amin, Daewa Zaheer, Raj K. Narayan, Sanjaya K. Satapathy, Patricia S. Latham, Kirti Shetty, Chandan Guha, Nancy R. Gough, Lopa Mishra. Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer. Genes & Cancer 2022; 13: 9 doi: 10.18632/genesandcancer.220
|
| 131 |
Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91164-9
|
| 132 |
Mathew Vithayathil, Maria Qurashi, Pedro Rente Vicente, Ali Alsafi, Mitesh Naik, Alison Graham, Shahid Khan, Heather Lewis, Ameet Dhar, Belinda Smith, Nowlan Selvapatt, Pinelopi Manousou, Lucia Possamai, Hooshang Izadi, Adrian Lim, Paul Tait, Rohini Sharma. Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on Ultrasound. Cancers 2024; 16(15): 2709 doi: 10.3390/cancers16152709
|
| 133 |
Young S. Rho, Ian Pagano, Linda L. Wong, Sandi A. Kwee, Jared D. Acoba. Factors and Survival Implications associated with biopsy of hepatocellular carcinoma. HPB 2021; 23(7): 1054 doi: 10.1016/j.hpb.2020.11.001
|
| 134 |
Masayuki Ueno, Haruhiko Takeda, Atsushi Takai, Hiroshi Seno. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives. World Journal of Gastroenterology 2022; 28(27): 3410-3421 doi: 10.3748/wjg.v28.i27.3410
|
| 135 |
Mounika Kanneganti, Jorge A. Marrero, Neehar D. Parikh, Fasiha Kanwal, Takeshi Yokoo, Mishal Mendiratta‐Lala, Nicole E. Rich, Purva Gopal, Amit G. Singal. Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review. Liver Transplantation 2022; 28(12): 1865 doi: 10.1002/lt.26562
|
| 136 |
Cody Criss, Arpit M Nagar, Mina S Makary. Hepatocellular carcinoma: State of the art diagnostic imaging. World Journal of Radiology 2023; 15(3): 56-68 doi: 10.4329/wjr.v15.i3.56
|
| 137 |
Han Li, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li. Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis. Expert Review of Gastroenterology & Hepatology 2023; 17(11): 1159 doi: 10.1080/17474124.2023.2279175
|
| 138 |
Delfino Y Li, Trang VoPham, Mei-Tzu C Tang, Christopher I Li. Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and Ethnicity. JNCI: Journal of the National Cancer Institute 2022; 114(9): 1238 doi: 10.1093/jnci/djac097
|
| 139 |
Felix Lu, Connor Ott, Prabha Bista, Xuanyong Lu. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC). Diagnostics 2024; 14(7): 725 doi: 10.3390/diagnostics14070725
|
| 140 |
Priscila Henriques da Silva, Matheus Menezes Gomes, Carla Adriana Loureiro de Matos, Ivonete Sandra de Souza e Silva, Adriano Miziara Gonzalez, Ulysses S. Torres, Gloria Maria Martinez Salazar, Giuseppe D'Ippolito. HCC Detection on Surveillance US. Journal of Ultrasound in Medicine 2021; 40(11): 2487 doi: 10.1002/jum.15637
|
| 141 |
Qimeng Chang, Yayun Xu, Jianfa Wang, Hui Jing, Longhua Rao, Weiguo Tang, Ziping Zhang, Xubo Wu, Jianxin Shi. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/8556888
|
| 142 |
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, Anna Garmpi, Iason Psilopatis, Panagiotis Sarantis, Evangelos Koustas, Prodromos Kanavidis, Dionysios Prevezanos, Gregory Kouraklis, Michail V. Karamouzis, Georgios Marinos, Konstantinos Kontzoglou, Efstathios A. Antoniou. Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review. International Journal of Molecular Sciences 2022; 23(22): 14117 doi: 10.3390/ijms232214117
|
| 143 |
Yun Bai, Dan Lu, Di Qu, Yiwen Li, Ning Zhao, Guanghua Cui, Xue Li, Xiaoke Sun, Yanying Liu, Meiqi Wei, Yu Yang, Zhongjie Shi. The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1844352
|